[Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver].
To observe therapeutic effect of acupoint-injection of Kaixilai on non-alcoholic fatty liver. One hundred cases of non-alcoholic fatty liver were randomly divided into a test group and a control group, 50 cases in each group. The test group were treated with injection of 2 mL Kaixilai injection into Zusanli (ST 36), thrice each week, for 3 months; and the control group were treated with intravenous drip of 200 mL Kaixilai injection, once each day, for 3 months. Changes of triglyceride (TG), total cholesterol (TC), malondialhyde (MDA), superoxide dismutase (SOD), glutamic-oxaloacetic transaminase (AST), glutamic-pyruvic transaminase (ALT), and clinical symptoms were observed in the two groups. There were significant differences before and after treatment in the symptoms, TG, TC, MDA, SOD, AST and ALT in the two groups (P<0.05), with no significant difference between the two groups (P>0.05). Acupoint-injection of Kaixilai is an effective therapy for non-alcoholic fatty liver, with convenience, economic and no adverse effect.